Steven Cohen Morphic Holding, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,461,302 shares of MORF stock, worth $83.3 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,461,302
Previous 1,461,302
-0.0%
Holding current value
$83.3 Million
Previous $49.8 Million
-0.0%
% of portfolio
0.14%
Previous 0.14%
Shares
14 transactions
Others Institutions Holding MORF
# of Institutions
68Shares Held
27.6MCall Options Held
4.2KPut Options Held
200K-
Black Rock Inc. New York, NY3.53MShares$201 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.06MShares$60.5 Million0.07% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il162KShares$9.23 Million0.0% of portfolio
-
Voloridge Investment Management, LLC Jupiter, FL161KShares$9.17 Million0.02% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY153KShares$8.71 Million0.01% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $2.19B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...